MIS416

· Innate Immunotherapeutics

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for MIS416, covering 2017-07-14 to 2017-07-14. Get the full timeline:

Most recent: Clinical Trial Update: Safety and Efficacy Study of MIS416 to Treat Secondary Progressive Multiple Sclerosis [Phase 2]